Stock Performance and Market Context
On 30 Jan 2026, Quick Heal Technologies Ltd’s stock recorded an intraday low of Rs.182.45, representing a 5.88% drop from the previous close. This decline followed two consecutive days of gains, signalling a reversal in short-term momentum. The stock underperformed its sector by 2.26% on the day, reflecting relative weakness within the Software Products industry segment.
Trading below all key moving averages — including the 5-day, 20-day, 50-day, 100-day, and 200-day averages — the stock’s technical indicators point to sustained downward pressure. This contrasts with the broader market, where the Sensex opened lower at 81,947.31, down 0.75%, and was trading at 82,071.42 by midday, still 4.98% shy of its 52-week high of 86,159.02. The Sensex itself remains below its 50-day moving average, though the 50DMA is positioned above the 200DMA, indicating mixed signals for the broader market.
Long-Term Performance and Valuation Metrics
Over the past year, Quick Heal Technologies Ltd has delivered a total return of -57.48%, significantly underperforming the Sensex’s 6.92% gain during the same period. The stock’s 52-week high was Rs.510, underscoring the steep decline it has experienced.
The company’s Mojo Score stands at 26.0, with a Mojo Grade of Strong Sell as of 2 Dec 2025, downgraded from a Sell rating. This reflects deteriorating fundamentals and valuation concerns. The Market Cap Grade is rated at 3, indicating a relatively modest market capitalisation compared to peers.
Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.
- - Consistent quarterly delivery
- - Proven staying power
- - Stability with growth
See the Consistent Performer →
Financial and Operational Indicators
Quick Heal Technologies Ltd’s long-term growth metrics reveal subdued performance. Net sales have declined at an annual rate of -0.80% over the last five years, while operating profit has contracted sharply by -179.58% during the same period. These figures highlight persistent challenges in expanding revenue and profitability.
Recent quarterly results for December 2025 were largely flat, offering little indication of an immediate turnaround. The company’s debtors turnover ratio for the half-year stood at a low 1.57 times, signalling slower collection cycles. Cash and cash equivalents were also at a modest Rs.6.84 crores, limiting liquidity buffers.
Non-operating income accounted for 155.65% of profit before tax in the latest quarter, suggesting that core business earnings remain under pressure. The stock’s earnings before interest, taxes, depreciation and amortisation (EBITDA) are negative, further underscoring the risk profile associated with the company’s current financial health.
Valuation and Risk Considerations
Compared to its historical averages, Quick Heal Technologies Ltd is trading at valuations that imply elevated risk. The stock’s profits have fallen by -102.3% over the past year, reflecting a significant erosion of earnings power. This has contributed to the stock’s underperformance relative to the BSE500 index over one year, three years, and the last three months.
Despite these challenges, the company maintains a low average debt-to-equity ratio of zero, indicating minimal leverage. Promoters remain the majority shareholders, providing a degree of ownership stability.
Quick Heal Technologies Ltd or something better? Our SwitchER feature analyzes this small-cap Software Products stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Current Situation
The stock’s fall to Rs.182.45 marks a significant milestone in its recent trajectory, reflecting a combination of subdued financial performance, valuation pressures, and market dynamics. While the broader market shows mixed signals, Quick Heal Technologies Ltd’s share price remains under pressure, trading well below all major moving averages and its 52-week high of Rs.510.
Investors and market participants will note the company’s low liquidity position, negative EBITDA, and declining profitability as key factors influencing the stock’s current valuation and risk profile. The downgrade to a Strong Sell rating by MarketsMOJO further emphasises the cautious stance on the stock based on its fundamentals and recent trends.
Market Overview
On the day of the stock’s new low, the Sensex was trading lower by 0.6%, reflecting a cautious market environment. The index’s proximity to its 52-week high contrasts with Quick Heal Technologies Ltd’s steep decline, highlighting the stock’s relative underperformance within the Software Products sector and the broader market.
Shareholding and Capital Structure
The company’s capital structure remains conservative with negligible debt, and promoter holdings continue to dominate the share register. This ownership concentration may provide some stability amid the stock’s recent volatility.
Conclusion
Quick Heal Technologies Ltd’s stock reaching a 52-week low of Rs.182.45 encapsulates a period of sustained challenges for the company. The combination of weak sales growth, declining profitability, and valuation concerns has contributed to the stock’s underperformance relative to benchmarks and peers. The current market environment and technical indicators suggest continued caution around the stock’s near-term prospects.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
